Jackson Creek Investment Advisors LLC Dynavax Technologies Corp Transaction History

Jackson Creek Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$9.93 - $17.44 $81,247 - $142,694	-8,182 Reduced 9.93%	74,253 $775,000
Q2 2022 Aug 04, 2022	SELL	$7.45 - $12.83 $50,332 - $86,679	-6,756 Reduced 7.57%	82,435 $1.19 Million
Q1 2022 May 03, 2022	BUY	$9.75 - $14.44 $869,612 - $1.29 Million	89,191 New	89,191 $967,000
Q3 2021 Nov 02, 2021	SELL	$9.16 - $19.83 $1.06 Million - $2.29 Million	-115,333 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$7.25 - $10.99 $98,005 - $148,562	-13,518 Reduced 10.49%	115,333 $1.14 Million
Q1 2021 May 27, 2021	BUY	$4.57 - $11.18 $588,849 - $1.44 Million	128,851 New	128,851 $1.27 Million

275

129M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.